Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Effects of Intensive Glucose Lowering in Type 2 Diabetes Announcements — June 6, 2008
NEJM Editorials and Perspective:
- Intensive Glycemic Control in the ACCORD and ADVANCE Trials, Robert G. Dluhy, M.D., and Graham T. McMahon, M.D., M.M.Sc.
- Glycemic Targets and Cardiovascular Disease, William T. Cefalu, M.D.
- Redefining Quality - Implications of Recent Clinical Trials, Harlan M. Krumholz, M.D., and Thomas H. Lee, M.D.
ACCORD Blood Sugar Strategy Announcement — February 6, 2008
Last updated: February 13, 2008
|